Wendy Luo, Ph.D., DABT, Bristol-Myers Squibb - Qepler Summits And Conferences

Wendy Luo, Ph.D., DABT

Associate Director, Drug Safety Evaluation
Bristol-Myers Squibb
New Jersey, USA
Bristol-Myers Squibb - Global Biopharmaceutical Company

Related Sessions:

2nd Annual Highly Potent APIs
Summit 2020

Assess and reduce manufacturing and handling challenges for highly potent active pharmaceutical ingredients.
  • 19 Feb 2020
  • Prague, CZ
  • Pharma
Day 1: Wednesday, 19 February 2020
CASE STUDY: To Be Announced
View Details